HK Stock MarketDetailed Quotes

02607 SH PHARMA

Watchlist
  • 10.280
  • +0.020+0.19%
Market Closed Sep 13 16:08 CST
38.08BMarket Cap8.47P/E (TTM)

SH PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Cash flow from operating activities
Earning before tax
5.28%3.6B
----
-26.11%5.17B
----
-25.14%3.42B
----
11.43%6.99B
----
9.59%4.56B
----
Profit adjustment
Investment loss (gain)
-622.31%-342.02M
----
73.90%-176M
----
117.54%65.48M
----
66.24%-674.26M
----
78.97%-373.27M
----
Impairment and provisions:
22.04%329.78M
----
30.64%841.24M
----
51.60%270.22M
----
360.73%643.93M
----
-3.90%178.24M
----
-Other impairments and provisions
-12.80%293.26M
----
-10.40%279.96M
----
54.49%336.32M
----
46,192.99%312.46M
----
8.25%217.69M
----
Revaluation surplus:
41.94%-114.29M
----
-85.03%-404.73M
----
-675.23%-196.84M
----
-206.18%-218.74M
----
-171.34%-25.39M
----
Asset sale loss (gain):
-88.91%-139.31M
----
93.57%-92.48M
----
94.83%-73.75M
----
-2,368.58%-1.44B
----
-23,988.34%-1.43B
----
-Loss (gain) on sale of property, machinery and equipment
-88.91%-139.31M
----
93.57%-92.48M
----
94.83%-73.75M
----
-2,368.58%-1.44B
----
-23,988.34%-1.43B
----
Depreciation and amortization:
5.97%1.25B
----
-1.36%2.38B
----
-0.99%1.18B
----
3.88%2.41B
----
1.44%1.19B
----
-Amortization of intangible assets
5.22%198.8M
----
-2.14%380.6M
----
-5.75%188.94M
----
-8.69%388.91M
----
-2.18%200.45M
----
-Other depreciation and amortization
-13.56%85.95M
----
-1.46%192.33M
----
16.79%99.43M
----
4.44%195.19M
----
-4.81%85.14M
----
Financial expense
-4.95%915.72M
----
9.47%1.86B
----
14.92%963.41M
----
8.49%1.7B
----
17.71%838.33M
----
Change of operating capital
Inventory (increase) decrease
-8.38%1.34B
----
67.61%-2.3B
----
344.06%1.46B
----
-122.17%-7.11B
----
-227.79%-597.24M
----
Accounts receivable (increase)decrease
25.37%-7.87B
----
36.20%-6.43B
----
-30.21%-10.54B
----
-63.78%-10.08B
----
-20.30%-8.1B
----
Accounts payable increase (decrease)
-68.98%1.62B
----
-63.74%4.59B
----
70.05%5.23B
----
118.29%12.65B
----
-19.00%3.08B
----
Special items of business
46.66%-68.55M
----
-55.73%-190.9M
----
-207.76%-128.52M
----
-170.75%-122.59M
----
-19.26%119.26M
----
Adjustment items of business operations
-66.96%583.86M
-108.65%-5.47B
11.44%5.42B
1,550.33%2.3B
361.60%1.77B
-5.35%-2.62B
-0.45%4.87B
-105.43%-158.75M
-133.38%-675.44M
-126.37%-2.49B
Net cash from operations
-68.55%515.3M
-108.65%-5.47B
10.29%5.23B
1,550.33%2.3B
394.58%1.64B
-5.35%-2.62B
-6.28%4.74B
-105.43%-158.75M
-125.62%-556.18M
-126.37%-2.49B
Cash flow from investment activities
Dividend received - investment
122.44%701.77M
4.18%120.9M
11.68%982.75M
23.04%714.04M
20.77%315.48M
38,581.96%116.05M
16.96%879.94M
14.62%580.31M
-13.61%261.21M
-99.20%300K
Sale of fixed assets
46.92%138.69M
-95.96%815.73K
11.73%179.15M
34.59%147.03M
-9.00%94.4M
-67.91%20.22M
-16.01%160.34M
50.90%109.24M
95.21%103.74M
362.59%62.99M
Purchase of fixed assets
7.35%-1.39B
-25.93%-871.62M
-10.64%-2.97B
-16.91%-2.28B
-46.70%-1.5B
-19.43%-692.12M
34.81%-2.68B
-9.67%-1.95B
10.89%-1.03B
0.71%-579.51M
Sale of subsidiaries
----
105.03%11.51M
-99.53%500K
----
----
--5.62M
-6.07%106.8M
--3.54M
----
----
Acquisition of subsidiaries
44.69%-83.51M
96.94%-4.03M
-323.42%-357.08M
38.99%-156.75M
20.64%-150.98M
22.31%-132.08M
92.69%-84.33M
74.56%-256.95M
77.69%-190.26M
-319.74%-170M
Recovery of cash from investments
-9.52%11.35B
8.92%10.05B
-8.54%26.88B
10.25%23.58B
15.83%12.54B
--9.23B
1,058.86%29.39B
1,021.22%21.39B
1,100.77%10.83B
----
Cash on investment
41.37%-8.4B
33.81%-7.1B
31.01%-27.38B
25.11%-25.38B
33.01%-14.33B
---10.73B
-1,160.67%-39.68B
-1,231.26%-33.89B
-1,852.30%-21.39B
----
Other items in the investment business
-167.90%-280.57M
-580.74%-365.84M
130.92%171.42M
670.90%378.77M
4,650.56%413.22M
38.07%76.1M
53.37%-554.36M
95.44%-66.35M
99.33%-9.08M
104.34%55.12M
Net cash from investment operations
177.76%2.03B
187.44%1.84B
80.02%-2.49B
78.70%-3B
77.10%-2.61B
-233.74%-2.11B
-107.35%-12.47B
-227.02%-14.08B
-257.63%-11.42B
69.01%-631.1M
Net cash before financing
361.05%2.55B
23.21%-3.63B
135.44%2.74B
95.11%-697.09M
91.85%-976.23M
-51.53%-4.73B
-710.04%-7.73B
-930.42%-14.24B
-1,072.13%-11.97B
0.49%-3.12B
Cash flow from financing activities
New borrowing
5.04%35.6B
-8.90%18.44B
31.95%64.2B
29.44%46.82B
30.14%33.9B
39.89%20.24B
29.55%48.65B
12.65%36.17B
146.99%26.05B
28.11%14.46B
Refund
6.68%-35.83B
14.68%-17.41B
-20.95%-72.34B
-16.20%-50.5B
-26.19%-38.39B
-32.18%-20.41B
-14.54%-59.81B
0.69%-43.46B
-63.21%-30.42B
-10.50%-15.44B
Issuance of bonds
-50.00%6B
-50.00%3B
0.03%15B
-20.00%12B
33.32%12B
0.04%6B
-21.06%14.99B
-6.23%15B
-9.98%9B
19.98%6B
Dividends paid - financing
20.87%-1.1B
32.40%-657.03M
-30.44%-4.92B
-38.72%-4.36B
-40.33%-1.39B
-97.72%-971.89M
-13.41%-3.77B
-8.23%-3.14B
-15.99%-993.22M
-23.55%-491.55M
Absorb investment income
-98.81%3.74M
----
-97.49%354.28M
-97.46%355.19M
-97.75%314.36M
-98.88%156.81M
8,239.98%14.12B
13,400.69%14B
25,097.43%14B
1,160.28%13.96B
Other items of the financing business
29.36%-911.59M
83.70%-113.39M
-0.48%-2.06B
-7.45%-1.52B
1.38%-1.29B
22.17%-695.79M
-629.79%-2.05B
-290.64%-1.42B
-288.42%-1.31B
-788.40%-894.02M
Net cash from financing operations
-26.67%3.76B
-24.64%3.25B
-98.09%231.85M
-83.70%2.8B
-68.55%5.13B
-75.49%4.31B
675.32%12.14B
648.59%17.16B
808.77%16.32B
501.61%17.59B
Effect of rate
-762.80%-8.19M
161.07%7.74M
55.14%-5.58M
-374.02%-60.84M
4.02%-948.93K
-1,914.09%-12.67M
75.28%-12.44M
123.86%22.2M
10.28%-988.68K
-95.99%698.35K
Net Cash
51.89%6.31B
8.37%-381.61M
-32.60%2.97B
-27.94%2.1B
-4.34%4.16B
-102.88%-416.49M
621.13%4.41B
220.26%2.91B
461.21%4.34B
6,923.67%14.47B
Begining period cash
12.09%27.5B
12.09%27.5B
21.83%24.53B
21.83%24.53B
21.83%24.53B
21.83%24.53B
2.87%20.14B
2.87%20.14B
2.87%20.14B
2.87%20.14B
Cash at the end
17.83%33.8B
12.53%27.13B
12.09%27.5B
15.17%26.57B
17.19%28.69B
-30.36%24.1B
21.83%24.53B
13.14%23.07B
20.30%24.48B
78.58%34.61B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Cash flow from operating activities
Earning before tax 5.28%3.6B-----26.11%5.17B-----25.14%3.42B----11.43%6.99B----9.59%4.56B----
Profit adjustment
Investment loss (gain) -622.31%-342.02M----73.90%-176M----117.54%65.48M----66.24%-674.26M----78.97%-373.27M----
Impairment and provisions: 22.04%329.78M----30.64%841.24M----51.60%270.22M----360.73%643.93M-----3.90%178.24M----
-Other impairments and provisions -12.80%293.26M-----10.40%279.96M----54.49%336.32M----46,192.99%312.46M----8.25%217.69M----
Revaluation surplus: 41.94%-114.29M-----85.03%-404.73M-----675.23%-196.84M-----206.18%-218.74M-----171.34%-25.39M----
Asset sale loss (gain): -88.91%-139.31M----93.57%-92.48M----94.83%-73.75M-----2,368.58%-1.44B-----23,988.34%-1.43B----
-Loss (gain) on sale of property, machinery and equipment -88.91%-139.31M----93.57%-92.48M----94.83%-73.75M-----2,368.58%-1.44B-----23,988.34%-1.43B----
Depreciation and amortization: 5.97%1.25B-----1.36%2.38B-----0.99%1.18B----3.88%2.41B----1.44%1.19B----
-Amortization of intangible assets 5.22%198.8M-----2.14%380.6M-----5.75%188.94M-----8.69%388.91M-----2.18%200.45M----
-Other depreciation and amortization -13.56%85.95M-----1.46%192.33M----16.79%99.43M----4.44%195.19M-----4.81%85.14M----
Financial expense -4.95%915.72M----9.47%1.86B----14.92%963.41M----8.49%1.7B----17.71%838.33M----
Change of operating capital
Inventory (increase) decrease -8.38%1.34B----67.61%-2.3B----344.06%1.46B-----122.17%-7.11B-----227.79%-597.24M----
Accounts receivable (increase)decrease 25.37%-7.87B----36.20%-6.43B-----30.21%-10.54B-----63.78%-10.08B-----20.30%-8.1B----
Accounts payable increase (decrease) -68.98%1.62B-----63.74%4.59B----70.05%5.23B----118.29%12.65B-----19.00%3.08B----
Special items of business 46.66%-68.55M-----55.73%-190.9M-----207.76%-128.52M-----170.75%-122.59M-----19.26%119.26M----
Adjustment items of business operations -66.96%583.86M-108.65%-5.47B11.44%5.42B1,550.33%2.3B361.60%1.77B-5.35%-2.62B-0.45%4.87B-105.43%-158.75M-133.38%-675.44M-126.37%-2.49B
Net cash from operations -68.55%515.3M-108.65%-5.47B10.29%5.23B1,550.33%2.3B394.58%1.64B-5.35%-2.62B-6.28%4.74B-105.43%-158.75M-125.62%-556.18M-126.37%-2.49B
Cash flow from investment activities
Dividend received - investment 122.44%701.77M4.18%120.9M11.68%982.75M23.04%714.04M20.77%315.48M38,581.96%116.05M16.96%879.94M14.62%580.31M-13.61%261.21M-99.20%300K
Sale of fixed assets 46.92%138.69M-95.96%815.73K11.73%179.15M34.59%147.03M-9.00%94.4M-67.91%20.22M-16.01%160.34M50.90%109.24M95.21%103.74M362.59%62.99M
Purchase of fixed assets 7.35%-1.39B-25.93%-871.62M-10.64%-2.97B-16.91%-2.28B-46.70%-1.5B-19.43%-692.12M34.81%-2.68B-9.67%-1.95B10.89%-1.03B0.71%-579.51M
Sale of subsidiaries ----105.03%11.51M-99.53%500K----------5.62M-6.07%106.8M--3.54M--------
Acquisition of subsidiaries 44.69%-83.51M96.94%-4.03M-323.42%-357.08M38.99%-156.75M20.64%-150.98M22.31%-132.08M92.69%-84.33M74.56%-256.95M77.69%-190.26M-319.74%-170M
Recovery of cash from investments -9.52%11.35B8.92%10.05B-8.54%26.88B10.25%23.58B15.83%12.54B--9.23B1,058.86%29.39B1,021.22%21.39B1,100.77%10.83B----
Cash on investment 41.37%-8.4B33.81%-7.1B31.01%-27.38B25.11%-25.38B33.01%-14.33B---10.73B-1,160.67%-39.68B-1,231.26%-33.89B-1,852.30%-21.39B----
Other items in the investment business -167.90%-280.57M-580.74%-365.84M130.92%171.42M670.90%378.77M4,650.56%413.22M38.07%76.1M53.37%-554.36M95.44%-66.35M99.33%-9.08M104.34%55.12M
Net cash from investment operations 177.76%2.03B187.44%1.84B80.02%-2.49B78.70%-3B77.10%-2.61B-233.74%-2.11B-107.35%-12.47B-227.02%-14.08B-257.63%-11.42B69.01%-631.1M
Net cash before financing 361.05%2.55B23.21%-3.63B135.44%2.74B95.11%-697.09M91.85%-976.23M-51.53%-4.73B-710.04%-7.73B-930.42%-14.24B-1,072.13%-11.97B0.49%-3.12B
Cash flow from financing activities
New borrowing 5.04%35.6B-8.90%18.44B31.95%64.2B29.44%46.82B30.14%33.9B39.89%20.24B29.55%48.65B12.65%36.17B146.99%26.05B28.11%14.46B
Refund 6.68%-35.83B14.68%-17.41B-20.95%-72.34B-16.20%-50.5B-26.19%-38.39B-32.18%-20.41B-14.54%-59.81B0.69%-43.46B-63.21%-30.42B-10.50%-15.44B
Issuance of bonds -50.00%6B-50.00%3B0.03%15B-20.00%12B33.32%12B0.04%6B-21.06%14.99B-6.23%15B-9.98%9B19.98%6B
Dividends paid - financing 20.87%-1.1B32.40%-657.03M-30.44%-4.92B-38.72%-4.36B-40.33%-1.39B-97.72%-971.89M-13.41%-3.77B-8.23%-3.14B-15.99%-993.22M-23.55%-491.55M
Absorb investment income -98.81%3.74M-----97.49%354.28M-97.46%355.19M-97.75%314.36M-98.88%156.81M8,239.98%14.12B13,400.69%14B25,097.43%14B1,160.28%13.96B
Other items of the financing business 29.36%-911.59M83.70%-113.39M-0.48%-2.06B-7.45%-1.52B1.38%-1.29B22.17%-695.79M-629.79%-2.05B-290.64%-1.42B-288.42%-1.31B-788.40%-894.02M
Net cash from financing operations -26.67%3.76B-24.64%3.25B-98.09%231.85M-83.70%2.8B-68.55%5.13B-75.49%4.31B675.32%12.14B648.59%17.16B808.77%16.32B501.61%17.59B
Effect of rate -762.80%-8.19M161.07%7.74M55.14%-5.58M-374.02%-60.84M4.02%-948.93K-1,914.09%-12.67M75.28%-12.44M123.86%22.2M10.28%-988.68K-95.99%698.35K
Net Cash 51.89%6.31B8.37%-381.61M-32.60%2.97B-27.94%2.1B-4.34%4.16B-102.88%-416.49M621.13%4.41B220.26%2.91B461.21%4.34B6,923.67%14.47B
Begining period cash 12.09%27.5B12.09%27.5B21.83%24.53B21.83%24.53B21.83%24.53B21.83%24.53B2.87%20.14B2.87%20.14B2.87%20.14B2.87%20.14B
Cash at the end 17.83%33.8B12.53%27.13B12.09%27.5B15.17%26.57B17.19%28.69B-30.36%24.1B21.83%24.53B13.14%23.07B20.30%24.48B78.58%34.61B
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data